PreEclampsia is a hypertensive disease that affects pregnant women after 20 weeks of gestation

Gender Screen, first commercially available genetic test with home sampling, done by taking a simple blood sample from the mother without any risk to the fetus

Non-Invasive Prenatal testing (Risk free) is a method of determining the risk of the fetus having certain genetic abnormalities